Hepatitis B Foundation President Dr. Chari Cohen is quoted in a powerful new story about hepatitis B in The New Yorker. You can read it here.

Our Research Institute

Our research program is bringing hope through the work of scientists at the Baruch S. Blumberg Institute. We sponsor activities that help keep the national research focus on hepatitis B and promote innovative scientific exchange among academia, industry and government.

Baruch S. Blumberg Institute

The Baruch S. Blumberg Institute is an independent 501(c)(3) nonprofit research institute that was established in 2003 by the Hepatitis B Foundation to advance its research mission. The Blumberg Institute supports programs dedicated to drug discovery, biomarker discovery and translational biotechnology around common research themes such as chronic hepatitis, liver disease, and liver cancer in an environment conducive to interaction, collaboration and focus.

With more than 30 scientists, the Blumberg Institute may now be the largest group of nonprofit researchers working on hepatitis B in the world.

To learn more about the Baruch S. Blumberg Institute, visit www.blumberginstitute.org.